카바페넴 항생물질의 중간체 및 그의 제조방법
    1.
    发明授权
    카바페넴 항생물질의 중간체 및 그의 제조방법 失效
    카바페넴항생물질의의간및및및및법법법

    公开(公告)号:KR100377448B1

    公开(公告)日:2003-03-26

    申请号:KR1020000046447

    申请日:2000-08-10

    Abstract: There is disclosed an azetidinone compound of the formula (I):wherein R is hydrogen, or a hydroxy protecting group, R1 and R2 are each independently alkyl of 1-15 carbon atoms, benzyl or cyclized together with the carbon atom to which they are attached to form a 5 or 6-membered cyclic hydrocarbon or a heterocyclic radical having one or two hetero ring atoms, said hetero ring atoms being selected from the group consisting of O and S; R3 is lower alkyl or -COO(lower alkyl) R4 is phenyl, or phenyl substituted with halogen, lower alkoxy or nitro which is useful as a synthetic intermediate to the 1'beta-methylcarbapenem-type antibacterial agent.

    Abstract translation: 公开了式(I)的氮杂环丁酮化合物:其中R是氢或羟基保护基,R 1和R 2各自独立地是1-15个碳原子的烷基,苄基或与它们所连接的碳原子一起环化 连接形成5或6元环烃或具有一个或两个杂环原子的杂环基,所述杂环原子选自O和S; R3是低级烷基或-COO(低级烷基),R4是苯基或被卤素,低级烷氧基或硝基取代的苯基,它可用作1'β-甲基碳代青霉烯类抗菌剂的合成中间体。

    신규한 항바이러스성 피롤로피리딘 유도체 및 이의 제조방법
    6.
    发明申请
    신규한 항바이러스성 피롤로피리딘 유도체 및 이의 제조방법 审中-公开
    新型抗吡啶吡啶衍生物及其生产方法

    公开(公告)号:WO2013073875A1

    公开(公告)日:2013-05-23

    申请号:PCT/KR2012/009689

    申请日:2012-11-15

    CPC classification number: C07D471/04

    Abstract: 본 발명은 하기 화학식 I로 표시되는 피롤로피리딘 유도체 및 이의 라세미체, 입체이성질체 또는 이의 약제학적으로 허용되는 염 및 이를 활성성분으로 함유하는 항바이러스제 조성물에 관한 것으로, 하기 화학식 I의 화합물은 야생형 및 내성 HIV-1에 대한 생리활성도 및 선택도가 우수하여 후천성면역결핍증(AIDS) 치료제로 유용하다.

    Abstract translation: 本发明涉及由下述化学式I表示的吡咯并吡啶衍生物及其相同的外消旋形式或立体异构形式或其相容的药学上可接受的盐,以及含有作为活性成分的抗病毒组合物。 以下化学式I化合物具有突出的生理活性,对野生型和耐药性HIV-1有选择性的作用,可用作获得性免疫缺陷综合征(AIDS)的治疗剂。

    카바페넴 항생물질의 중간체 및 그의 제조방법
    7.
    发明授权
    카바페넴 항생물질의 중간체 및 그의 제조방법 失效
    카바페넴항생물질의의간및및및및법법법

    公开(公告)号:KR100385364B1

    公开(公告)日:2003-05-27

    申请号:KR1020020052421

    申请日:2002-09-02

    Abstract: PURPOSE: Provided are azetidinone compound of the formula(I) as an intermediate useful for the manufacture of carbapenem antibiotics and a process for the preparation thereof. CONSTITUTION: The azetidine compound is represented by the formula(I). It is useful as an intermediate for the manufacture of beta-methylcarbapenem antibiotics and manufactured by reacting 4-acetoxy-azetidine compound of the formula(II) and alpha-halo propionic acid amide compound of the formula(III).

    Abstract translation: 目的:提供式(I)的氮杂环丁酮化合物作为可用于制备碳青霉烯类抗生素的中间体及其制备方法。 构成:氮杂环丁烷化合物由式(I)表示。 它可用作制备β-甲基碳青霉烯类抗生素的中间体,并通过使式(II)的4-乙酰氧基 - 氮杂环丁烷化合物与式(III)的α-卤代丙酰胺化合物反应制备。

    카바페넴 항생물질의 중간체 및 그의 제조방법
    10.
    发明公开
    카바페넴 항생물질의 중간체 및 그의 제조방법 失效
    卡巴因抗生素的中间体及其制备方法

    公开(公告)号:KR1020020013988A

    公开(公告)日:2002-02-25

    申请号:KR1020000046447

    申请日:2000-08-10

    Abstract: PURPOSE: Provided is an intermediate, azetidinone compound which is useful in manufacturing beta-methylcarbapenem antibiotics. And its manufacturing method is provided. CONSTITUTION: The intermediate of carbapenem, azetidinone compound, is represented by the formula(1), wherein R is hydrogen or hydroxy protective group, R1 and R2 are individually C1-C15 alkyl, benzyl, represent 5-6 membered cyclic compound to which R1 and R2 are linked, or hetero cyclic group including at least one oxygen or sulfur atom; R3 is lower alkyl group or lower alkylester group; and R4 is benzene, halogen, lower alkyloxy group, or nitro group substituted benzene ring.

    Abstract translation: 目的:提供可用于制备β-甲基碳青霉烯类抗生素的中间体氮杂环丁酮化合物。 并提供其制造方法。 构成:碳青霉烯类氮杂环丁酮化合物的中间体由式(1)表示,其中R是氢或羟基保护基,R1和R2分别是C1-C15烷基,苄基,代表5-6元环状化合物,其中R1 或R 2连接,或包含至少一个氧原子或硫原子的杂环基; R3是低级烷基或低级烷基酯基; R4为苯,卤素,低级烷氧基或硝基取代苯环。

Patent Agency Ranking